In this study, we investigated the role of TGF-β signaling in the progression and aggressiveness of ccRCC with emphasis on ALK5-FL, ALK5-ICD, pSmad2/3, and PAI-1. This evidence concerns the gene TGFBR1 and nonpapillary renal cell carcinoma.